For example, the use of anti-angiogenic therapies, which target the formation of new blood vessels, has proven successful in cancer treatment, with anti-VEGFA antibodies currently being used to treat patients with metastatic colorectal cancer (163, 164). The gene discussed is VEGFA; the disease is metastatic colorectal cancer.